[2P-0516] In silico drug screening by using genome-wide association study (GWAS)-data repurposed a novel disease-modifying drug for Parkinson’s disease

〇TAKESHI UENAKA¹, WATARU SATAKE¹, Pei-Chieng Cha¹, HIDEKI HAYAKAWA², KOUSUKE BABA², SHIYING JIANG², KAZUHIRO KOBAYASHI¹, MOTOI KANAGAWA¹, YUKINORI OKADA^3,4, HIDEKI MOCHIZUKI², TATSUSHI TODA^5,1 (1.Div of Neurol/Mol Brain Sci, Kobe Univ Graduate School of Med, 2.Dep of Neurol, Osaka Univ Graduate School of Med, 3.Dep of Statistical Genetics, Osaka Univ Graduate School of Med, 4.Lab of Statistical Immunol, Immunol Frontier Research Center (WPI-IFReC), Osaka Univ, 5.Dep of Neurol, Graduate School of Med, The Univ of Tokyo)

Parkinson's disease, drug repurposing, genome-wide association study